KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), and Infinimmune, Inc., a biotechnology company pioneering human-first antibody discovery and design, announced a collaboration to advance manufacturing of Infinimmune’s lead human monoclonal antibody (“IFX-101”) program. The first antibody in Infinimmune’s therapeutic drug development pipeline, IFX-101, targets atopic dermatitis and is designed to deliver superior effica...

Deep Fission, Inc. (“Deep Fission” or the “Company”), a pioneering advanced nuclear energy company placing small modular pressurized water reactors in boreholes one mile underground, announced today it raised $30M in a heavily oversubscribed private placement offering at $3.00 per share as well as completed a go-public reverse merger transaction with Surfside Acquisition Inc., which has been renamed Deep Fission, Inc. The Department of Energy (DOE) recently announced that Deep Fission was sel...

AEM (aem.eco), the essential source for environmental insights, today announced the acquisition of Van Essen Instruments, a renowned provider of precision groundwater and surface water monitoring systems. Through this acquisition, AEM integrates Van Essen’s rugged sensor hardware, telemetry solutions, and robust data management tools into the AEM Elements® environmental resiliency platform, delivering a unified solution for monitoring water, weather, and other environmental risks. For more th...